Today: May 26, 2024
January 23, 2024
1 min read

Elephas Raises $55M: Fueling Future Growth with Series C

Elephas, a private company developing an oncology imaging diagnostics platform, has raised $55 million in Series C funding. The funding round was led by Venture Investors Health Fund and the State of Wisconsin Investment Board, with participation from other investors including Northpond Ventures and ARCH Ventures. Elephas aims to use the funding to advance its live tumor imaging diagnostic platform, which uses metabolic imaging and live patient biopsies to predict response to immunotherapy. The company is conducting observational clinical trials to demonstrate the correlation between a patient’s clinical response to immunotherapy and data obtained from the Elephas platform.

Previous Story

Myriad Venture Partners: Pioneering the Future of Investment in Tech

Next Story

Unleashing Web3 Potential: Paper Ventures Kickstarts Early Stage Funding

Latest from Blog

Go toTop